EVALUATE THE EFFECTIVENESS OF KADUKKAI LEGIUM FOR THE MANAGEMENT OF MALAKATTU IN CHILDREN

AN OPEN CLINICAL TRIAL TO EVALUATE THE EFFECTIVENESS OF KADUKKAI LEGIUM FOR THE MANAGEMENT OF(MALAKATTU) FUNCTIONAL CONSTIPATION IN CHILDREN - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/07/069856

Enrollment

Registered

2024-07-03

Start date

Unknown

Completion date

Unknown

Last updated

2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K929- Disease of digestive system, unspecified

Interventions

Intervention1: Internal Medicine-Kadukkai Legium : Dose-Punnaikayalavu(8 grams) 5-8 years :3.2 grams 9-12 years:4 grams Duration-28 days Control Intervention1: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: 1 The patients are selected in accordance with the Rome IV criteria 2 Participation requires the willingness of either the patient or their parent/legal guardian to provide informed consent for the study.

Exclusion criteria

Exclusion criteria: 1. Intolerable Stomach Pain 2. Hirschsprung Disease 3. Rectal Prolapse 4. Congenital Hypothyroidism 5. Duodenal Atresia 6. Anorectal Malformations

Design outcomes

Primary

Measure	Time frame
The outcome of the will be determined using Bristol stool scale Timepoint: The outcome of the will be determined using Bristol stool scale for 4 weeks	—

Secondary

Measure	Time frame
NilTimepoint: Nil	—

Countries

India

Contacts

Public ContactDr M Shanmugeshwari

National Institute of siddha

drarulmozhi2012@gmail.com9500151930

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026